Literature DB >> 17720020

Polycystic ovary syndrome.

Robert J Norman1, Didier Dewailly, Richard S Legro, Theresa E Hickey.   

Abstract

Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720020     DOI: 10.1016/S0140-6736(07)61345-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  335 in total

Review 1.  Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents.

Authors:  Emily S Jungheim; Anthony O Odibo
Journal:  Fertil Steril       Date:  2010-05-07       Impact factor: 7.329

2.  Insulin-stimulated glucose uptake occurs in specialized cells within the cumulus oocyte complex.

Authors:  Scott H Purcell; Maggie M Chi; Susan Lanzendorf; Kelle H Moley
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

Review 3.  Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.

Authors:  Kristen Farrell; Michael H Antoni
Journal:  Fertil Steril       Date:  2010-05-14       Impact factor: 7.329

Review 4.  Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion.

Authors:  Michael N Lehman; Lique M Coolen; Robert L Goodman
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

5.  Long non-coding RNA TUG1 and its molecular mechanisms in polycystic ovary syndrome.

Authors:  Ying Li; Jun Zhang; Yu-Dong Liu; Xing-Yu Zhou; Xin Chen; Jing Zhe; Qing-Yan Zhang; Xiao-Fei Zhang; Ying-Xue Chen; Zhe Wang; Shi-Ling Chen
Journal:  RNA Biol       Date:  2020-07-02       Impact factor: 4.652

6.  Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome.

Authors:  Nina M Clark; Amanda J Podolski; Eric D Brooks; Donna R Chizen; Roger A Pierson; Denis C Lehotay; Marla E Lujan
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

7.  Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria.

Authors:  Miro Šimun Alebić; Tomislav Bulum; Nataša Stojanović; Lea Duvnjak
Journal:  Endocrine       Date:  2014-02-13       Impact factor: 3.633

8.  Role for androgens in determination of ovarian fate in the common snapping turtle, Chelydra serpentina.

Authors:  Anthony Schroeder; Turk Rhen
Journal:  Gen Comp Endocrinol       Date:  2019-05-03       Impact factor: 2.822

Review 9.  Prenatal and postnatal hormone effects on the human brain and cognition.

Authors:  Bonnie Auyeung; Michael V Lombardo; Simon Baron-Cohen
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

10.  Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome.

Authors:  Mohadetheh Moulana
Journal:  Life Sci       Date:  2019-01-29       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.